SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-099802
Filing Date
2022-04-08
Accepted
2022-04-08 09:25:32
Documents
12
Period of Report
2022-04-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d329248d8k.htm   iXBRL 8-K 28311
  Complete submission text file 0001193125-22-099802.txt   151010

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kldo-20220408.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kldo-20220408_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kldo-20220408_pre.xml EX-101.PRE 11258
6 EXTRACTED XBRL INSTANCE DOCUMENT d329248d8k_htm.xml XML 3335
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 22815591
SIC: 2836 Biological Products, (No Diagnostic Substances)